MS BIOZONE
Live / Registered — Registered (as of 22 Aug 2023)
What this means for you
Registered since 22 Aug 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79354912
- Registration number
- 7141432
- Mark type
- Stylized text
- Filed
- 15 Sept 2022
- Published for opposition
- 06 Jun 2023
- Registered
- 22 Aug 2023
Goods and services
- Class 041 — Education and entertainment services: Organization and conducting of seminars with respect to biosimilar medicine and neurology; organization and conducting of conferences with respect to biosimilar medicine and neurology; organization and conducting of congresses with respect to biosimilar medicine and neurology; organization and conducting of symposiums with respect to biosimilar medicine and neurology; organization and conducting of workshops with respect to biosimilar medicine and neurology; organization and conducting of training and further training courses with respect to biosimilar medicine and neurology; providing continuing medical education courses with respect to biosimilar medicine and neurology
Owner
- Sandoz AG, CH
- Novartis AG, CH
- Novartis AG, CH
- Novartis AG, CH
Prosecution history
- 22 Jan 2024 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 19 Jan 2024 — CHANGE OF OWNER RECEIVED FROM IB
- 28 Nov 2023 — FINAL DISPOSITION NOTICE SENT TO IB
- 28 Nov 2023 — FINAL DISPOSITION PROCESSED
- 22 Nov 2023 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 22 Aug 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 22 Aug 2023 — REGISTERED-PRINCIPAL REGISTER
- 06 Jun 2023 — NOTIFICATION PROCESSED BY IB
- 06 Jun 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Jun 2023 — PUBLISHED FOR OPPOSITION
- 17 May 2023 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 17 May 2023 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 17 May 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 May 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Apr 2023 — REFUSAL PROCESSED BY IB